Koninklijke Philips N.V. Stock (RYLPF.US) Real-time Quotes - Financial Data - Analyst Ratings

Company Encyclopedia

Koninklijke Philips N.V.

RYLPF.US

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.

1.388 T

RYLPF.USMarket value -Rank by Market Cap -/-

Financial Score

16/12/2025 Update

Health Care EquipmentIndustry

Industry Ranking47/171

Industry medianC

Industry averageC

Score Analysis

Peer Comparison

Criteria
Rating
Profit ScoreC
- ROE0.00%D
- Profit Margin0.93%C
- Gross Margin44.40%B
Growth ScoreC
- Revenue YoY0.76%C
- Net Profit YoY151.43%A
- Total Assets YoY0.00%C
- Net Assets YoY-6.74%D
Cash ScoreB
- Cash Flow Margin10775.76%A
- OCF YoY0.76%C
Operating ScoreE
- Turnover0E
Debt ScoreD
- Gearing Ratio59.82%D

Valuation analysis

P/E

10Y

P/E

Industry Ranking

-/-

P/E
Price
High
Median
Low

P/B

10Y

P/B

Industry Ranking

-/-

P/B
Price
High
Median
Low

P/S

10Y

P/S

Industry Ranking

-/-

P/S
Price
High
Median
Low

Dividend Yield

10Y

Dividend Yield

Industry Ranking

-/-

Dividend Yield
Price
High
Median
Low

Institutional View & Shareholder

Analyst Ratings

Rating

Percentage

Price
--
Highest
--
Lowest
--

Shareholder

Ownership	%Owned	Share Chg	Report Date
Exor N.V.	19.2%	No Change	30/09/2025
Artisan Partners Limited Partnership	9.9%	No Change	28/06/2024
BlackRock, Inc.	4.02%	-40.00 K	30/09/2025
Mondrian Investment Partners Limited	3.54%	794.94 K	30/09/2025
The Vanguard Group, Inc.	3.52%	-106.50 K	31/10/2025
T. Rowe Price Group, Inc.	3.02%	No Change	29/10/2024
Causeway Capital Management LLC	1.73%	145.17 K	31/10/2025
Norges Bank Investment Management	1.48%	No Change	30/06/2025
Fiduciary Management, Inc.	1.17%	-2.09 M	30/09/2025
Pzena Investment Management, Inc.	1%	23.64 K	30/09/2025

News

Strong performance in the North American market boosts Philips' Q3 comparable sales growth by 3%, adjusted EBITA exceeds expectations

Dutch medical technology company Koninklijke Philips N.V. announced its third-quarter results for 2025, with sales declining 2% year-on-year to €4.302 billion, but comparable sales grew by 3%. Comparable sales in North America increased by 5%. Adjusted EBITA was €531 million, exceeding market expectations of €484 million. The CEO stated that the performance reflects investments in the supply chain to mitigate tariff impacts

Zhitong·11/04/2025 16:08

Zhitong·11/04/2025 16:08

Philips: The free cash flow is expected to remain between 200 million and 400 million euros in 2025

Zhitong·11/04/2025 14:08

Zhitong·11/04/2025 14:08

B-Soft: Recently, Koninklijke Philips N.V. reduced its stake in the company by 1.02%

B-Soft announced that the company received a "Notice Letter" issued by Koninklijke Philips N.V., stating that Philips will reduce its holdings in the company by a total of 15.79 million shares through centralized bidding and block trading from September 25, 2025, to October 10, 2025. The proportion of shares held by Philips will decrease from 9.999996% to 8.977366%, accounting for 1.019528% of the company's total share capital. This change in equity will not lead to a change in the company's control and will not have a significant impact on the company's governance structure and ongoing operations

Zhitong·10/14/2025 19:07

Zhitong·10/14/2025 19:07

"European Stocks" European stocks fell in the early session, with the French and German markets down 0.4%, and healthcare stocks declining

European stocks fell in early trading, with healthcare stocks under pressure as the market awaited comments from Federal Reserve officials and U.S. economic data. The pan-European STOXX 600 index dropped 0.3%, while the French CAC 40 and German DAX indices both fell 0.4%. The U.S. Department of Commerce launched an investigation into imported medical devices, leading to declines in the stock prices of Siemens Healthineers and Koninklijke Philips N.V. H&M's quarterly earnings significantly exceeded expectations, with its stock price rising 10%. Asia-Pacific stock markets showed mixed performance, with the Shanghai Composite slightly down and Hong Kong stocks experiencing a small decline

AASTOCKS·09/25/2025 17:02

AASTOCKS·09/25/2025 17:02